Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) General Counsel David O. Watson Sells 781 Shares
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) General Counsel David O. Watson sold 781 shares of the business’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $67.77, for a total value of $52,928.37. Following the completion of the transaction, the general counsel now owns 103,390 […]
More Stories
Rocket Pharmaceuticals (NASDAQ:RCKT) Earns “Buy” Rating from Chardan Capital
Chardan Capital reaffirmed their buy rating on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report published on...
Calumet Specialty Products Partners (NASDAQ:CLMT) Rating Increased to Sell at StockNews.com
StockNews.com upgraded shares of Calumet Specialty Products Partners (NASDAQ:CLMT – Free Report) to a sell rating in a research report...
Pure Cycle (NASDAQ:PCYO) Upgraded at StockNews.com
StockNews.com upgraded shares of Pure Cycle (NASDAQ:PCYO – Free Report) from a sell rating to a buy rating in a...
HP Inc. (NYSE:HPQ) Shares Acquired by Swiss National Bank
Swiss National Bank lifted its holdings in shares of HP Inc. (NYSE:HPQ – Free Report) by 0.3% in the 3rd...
Swiss National Bank Grows Holdings in Old Dominion Freight Line, Inc. (NASDAQ:ODFL)
Swiss National Bank grew its holdings in Old Dominion Freight Line, Inc. (NASDAQ:ODFL – Free Report) by 0.1% during the...
Swiss National Bank Buys 25,000 Shares of PG&E Co. (NYSE:PCG)
Swiss National Bank lifted its stake in PG&E Co. (NYSE:PCG – Free Report) by 0.4% during the 3rd quarter, according...